MetaCap

iSpecimen (ISPC) vs ENDRA Life Sciences (NDRA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

ENDRA Life Sciences is the larger company by market cap ($8.9 million vs $2.7 million), about 3.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ISPC-0.91%NDRA-2.15%
+0%-1%-2%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ISPC versus NDRA key metrics
MetricISPCNDRA
Share price$1.09$5.93
Market cap$2.75M$8.89M
1-day change-0.91%-2.15%
EPS (TTM)$-52.98$-6.26
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$37.60$9.85
52-week low$1.02$2.96
Distance from 52-week high-97.10%-39.80%
Analyst consensus—none
Avg. price target upside—+321.59%
Average volume667.50K34.65K
Shares outstanding2.52M1.50M
Employees79
SectorHealthcareHealthcare
IndustryDiagnostics & ResearchDiagnostics & Research

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ENDRA Life Sciences is about 3.2 times larger than iSpecimen by market value ($8.89M vs $2.75M).

About iSpecimen

ISPC stock →

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Healthcare · Diagnostics & Research · 7 employees

About ENDRA Life Sciences

NDRA stock →

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound.

Healthcare · Diagnostics & Research · 9 employees

ISPC vs NDRA FAQ

Which is bigger, iSpecimen or ENDRA Life Sciences?

ENDRA Life Sciences (NDRA) is larger, with a market capitalization of $8.89M compared with $2.75M for iSpecimen (ISPC).

Are iSpecimen and ENDRA Life Sciences in the same industry?

Yes. Both are classified in the Diagnostics & Research industry within the Healthcare sector.

More comparisons